OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
44
Results
Show all
Save search
Copy query
Show results for
Unknown
(44)
Publication Date
Release Date
2024
(11)
2021
(11)
2023
(6)
2025
(5)
2026
(3)
2019
(2)
2013
(2)
2022
(1)
2015
(1)
2012
(1)
2010
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Sleep and Caregiver Burden Among Caregivers of Persons Living With Dementia: A Scoping Review.
Not available
S-EPMC10901478
|
biostudies-literature
Cite
Insomnia symptoms among caregivers of persons with cognitive decline in an outpatient memory clinic.
Not available
S-EPMC11663100
|
biostudies-literature
Cite
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy.
Not available
S-EPMC10843468
|
biostudies-literature
Cite
Substitution of One Meat-Based Meal With Vegetarian and Vegan Alternatives Generates Lower Ammonia and Alters Metabolites in Cirrhosis: A Randomized Clinical Trial.
Not available
S-EPMC11196077
|
biostudies-literature
Cite
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
Not available
S-EPMC6716679
|
biostudies-literature
Cite
Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.
Not available
S-EPMC2857649
|
biostudies-literature
Cite
Protocol for #iBeatCRC: a community-based intervention to increase early-onset colorectal cancer awareness using a sequential explanatory mixed-methods approach.
Not available
S-EPMC8647393
|
biostudies-literature
Cite
High-Strength Organic-Inorganic Composites with Superior Thermal Insulation and Acoustic Attenuation.
Not available
S-EPMC10870751
|
biostudies-literature
Cite
Understanding Associations Between Patient-Level Factors and Participation in a Breast Cancer Clinical Trial.
Not available
S-EPMC12367865
|
biostudies-literature
Cite
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer.
Not available
S-EPMC8792110
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets